William Frazier Sells 10,000 Shares of Viemed Healthcare (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) insider William Frazier sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the sale, the insider owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. This represents a 12.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Viemed Healthcare Stock Performance

Shares of VMD stock opened at $11.63 on Friday. The company has a market capitalization of $445.89 million, a price-to-earnings ratio of 31.43 and a beta of 1.12. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. The company has a 50-day simple moving average of $9.91 and a 200 day simple moving average of $8.84. Viemed Healthcare, Inc. has a 52 week low of $5.93 and a 52 week high of $11.88.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.03). The company had revenue of $75.41 million during the quarter, compared to the consensus estimate of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. On average, sell-side analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Viemed Healthcare by 101.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after buying an additional 358,863 shares in the last quarter. Segall Bryant & Hamill LLC bought a new position in Viemed Healthcare during the third quarter worth about $1,965,000. Wasatch Advisors LP increased its position in Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock worth $10,683,000 after acquiring an additional 240,346 shares during the period. Hillsdale Investment Management Inc. acquired a new stake in Viemed Healthcare in the 1st quarter worth about $1,834,000. Finally, Two Sigma Investments LP boosted its holdings in Viemed Healthcare by 193.7% in the 3rd quarter. Two Sigma Investments LP now owns 251,410 shares of the company’s stock valued at $1,707,000 after purchasing an additional 165,797 shares during the period. Institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.